Chakameh Azimpour PhD Capsida Biotherapeutics

Dr. Chakameh Azimpour is an experienced leader with extensive expertise in regulatory applications, project management, and digital and continuous improvement. Currently serving as a director, she leads a high-performing technical team in Analytical Development at Capsida Biotherapeutics, a pioneering company in gene therapy. Her responsibilities include providing technical leadership for analytical development and quality control aspects in portfolio programs, as well as managing laboratory operations such as method development, qualification, and transfer to quality control. Additionally, she ensures compliance with FDA, cGMPs, ICH guidelines, and follows QBD principles and industry best practices in all analytical and quality control processes. Beyond her work in the industry, she has also dedicated more than 12 years to sharing her knowledge, teaching both theoretical principles and practical skills at academic institutions. She is currently a board member at Conejo School Foundation, an independent 501(c)(3) non-profit organization that supports student's achivement. she holds a Ph.D. in Microbiology/Genetics from the University of Vienna. During her leisure time, she volunteers, enjoys reading, cooking and baking, and cherishes moments with family and friends.